Enzymatic assays for the diagnosis of bradykinin-dependent angioedema (Q34934680)

5 August 2017

title

Enzymatic assays for the diagnosis of bradykinin-dependent angioedema (English)

1 reference

5 August 2017

9

Sven Cichon

0 references

Christian Drouet

object named as

Christian Drouet

13

0 references

Olivier Fain

11

object named as

Olivier Fain

1 reference

5 August 2017

Federica Defendi

1

1 reference

5 August 2017

Delphine Charignon

2

1 reference

5 August 2017

Arije Ghannam

3

1 reference

5 August 2017

Remi Baroso

4

1 reference

5 August 2017

Françoise Csopaki

5

1 reference

5 August 2017

Marion Allegret-Cadet

6

1 reference

5 August 2017

Denise Ponard

7

1 reference

5 August 2017

Bertrand Favier

8

1 reference

5 August 2017

Brigitte Nicolie

10

1 reference

5 August 2017

Ludovic Martin

12

1 reference

5 August 2017

National Reference Centre for Angioedema CREAK

14

1 reference

5 August 2017

language of work or name

English

0 references

publication date

5 August 2013

1 reference

5 August 2017

1 reference

5 August 2017

volume

8

1 reference

5 August 2017

issue

8

1 reference

5 August 2017

page(s)

e70140

1 reference

Creative Commons Attribution 4.0 International

5 August 2017

copyright license

start time

5 August 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

Limit of blank, limit of detection and limit of quantitation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

Nonallergic angioedema: role of bradykinin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

The kallikrein-kinin system: current and future pharmacological targets.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

Hereditary angioedema with normal C1-inhibitor activity in women

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

Estrogen induction and contact phase activation of human factor XII.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

An IgG autoantibody which inactivates C1-inhibitor

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

Release of histamine and arachidonate from mouse mast cells induced by glycosylation-enhancing factor and bradykinin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy.

8 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0070140

Type III hereditary angio-oedema: clinical and biological features in a French cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0070140

Angio-oedema induced by oestrogen contraceptives is mediated by bradykinin and is frequently associated with urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0070140

Upregulation of tissue kallikrein, kinin B1 receptor, and kinin B2 receptor in mast and giant cells infiltrating oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0070140

Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3734293

Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene

26 October 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0070140

Hereditary angioedema: a bradykinin-mediated swelling disorder

21 January 2018

1 reference

12 December 2020

Lymphoproliferative disease and acquired C1 inhibitor deficiency

1 reference

12 December 2020

Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein

1 reference

12 December 2020

Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma

1 reference

12 December 2020

Plasma kallikrein: novel functions for an old protease

1 reference

12 December 2020

Hereditary Angioedema: the Clinical Syndrome and Its Management

1 reference

12 December 2020

Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission

1 reference

12 December 2020

Hereditary angioedema precipitated by estrogen replacement therapy in a menopausal woman

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0070140

Identifiers

DOI

1 reference

5 August 2017

0 references

1 reference

5 August 2017

1 reference